2022-2029 年全球人体成分监测器市场

市场动态

肥胖患病率的上升和政府在促进健康生活方式方面的努力推动了身体成分测量市场的发展。

政府加大力度推广健康的生活方式，推动了身体成分测量市场的发展。

为了解决超重的主要社会和环境决定因素以及潜在的不健康生活方式，世界各国已显着扩大了政策行动。政府在解决生活方式行为和人民健康、减少健康不平等和慢性病方面可以发挥关键作用。政府参与包括监督、计划、研究、质量保证、医疗保健以及饮食和身体活动 (PA) 指南。一些人将政府视为父权制，并支持个人选择。但政府有机会跨部门开展工作，并让私营部门参与整合各种方法。因此，政府促进健康生活方式的举措将提高人们对使用身体成分分析仪来评估体内脂肪和无脂肪质量百分比的认识。

越来越多的肥胖患者将推动身体成分测量市场。

根据 A-Mansia Biotech 的数据，从 1975 年到 2020 年，全球肥胖患病率几乎增加了两倍。事实上，到 2020 年，将有超过 20 亿成年人（占全球成年人口的 39%）超重（BMI>25）。其中，超过 6 亿人肥胖（BMI>30）。在欧洲，超过一半的人口超重（BMI>25），高达 30% 的人口肥胖（BMI>30）。此外，世界肥胖联盟发布的《2022 年世界肥胖地图集》预测，到 2030 年，将有 10 亿人患有肥胖症，其中包括五分之一的女性和七分之一的男性。我来了。体重是肥胖最常用的指标。超重的人通常有更多的身体脂肪。体重的变化对应于体内水分、体脂肪和瘦肉组织的变化。身体成分是将您的身体分成其核心成分的一种方式：脂肪、矿物质、蛋白质和身体水分。与传统方法相比，您可以更准确地描述您的体重，并更好地了解您的整体健康状况。身体成分分析可以显示脂肪量、肌肉量和体脂百分比的真实变化。既然您已经超出了 BMI（身体质量指数），那么进行 BCA 有很多好处。健康比减肥更重要。有一些重要的因素，例如增加运动量和提高肌肉与脂肪的比例。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

与身体成分监测器相关的缺点抑制了它们的市场。

现代技术和评估有助于推进体脂分析，但仍存在某些缺点，尤其是取决于所选择的方法。体脂分析方法的一个局限性是它只考虑了少数允许大量错误空间的区域。这个缺点可以通过重复使用同一个部位来观察身体脂肪随时间的变化来避免。生物电阻抗是一个不太完美的概念，因为它以如此高的速度运行，以至于损害了准确性。除了脂肪，你体内的水分含量也会影响你的反应时间，食物也是如此。

根据一个人的居住地，DEXA 扫描可能非常昂贵，以及周围有多少中心、健身俱乐部和健康中心来携带必要的设备。这是先进的技术，您的社区或城镇可能没有太多选择。

行业分析

Body Composition Monitor Market 根据未满足的需求、定价分析、供应链分析和监管分析等各种行业因素对市场进行深入分析。

COVID-19 影响分析

预计 COVID-19 大流行将对市场产生相当积极的影响。正如一些研究表明的那样，肥胖患者感染 COVID-19 的风险更高。此外，由于锁门和居家令，人们比以前更久坐不动。因此，这推动了身体成分仪市场。

全球人体成分监测器市场报告提供大约 45 多个市场数据表、40 多个图表和 180 页内容。

内容

第 1 章研究方法与范围

• 调查方法
• 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

• 按产品划分的市场细分
• 最终用户的市场细分
• 按地区划分的市场细分

第 4 章市场动态

• 市场影响因素
  • 促进因素
    • 随着肥胖患者数量的增加，身体成分分析仪的市场扩大
    • 政府增加促进健康生活方式的举措推动了身体成分监测市场
  • 抑制因素
    • 与身体成分监测器相关的缺点阻碍了市场。
  • 机会
  • 影响分析

第 5 章行业分析

• 波特五力分析
• 流行病学分析
• 供应链分析
• 定价分析
• 监管分析
• 保险报销分析
• 未满足的需求

第 6 章 COVID-19 分析

• COVID-19 的市场分析
  • COVID-19 之前的市场情景
  • COVID-19 的当前市场情景
  • COVID-19 后或未来情景
• COVID-19 期间的价格动态
• 供需范围
• 大流行期间与市场相关的政府举措
• 製造商的战略举措
• 总结

第 7 章按产品分类

• 生物阻抗分析仪
• 双能X射线吸收测量装置
• 皮褶卡尺
• 空气置换式体积描记装置
• 其他

第 8 章最终用户

• 医院
• 健身俱乐部/健康中心
• 其他

第 9 章按地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 10 章竞争格局

• 主要发展和战略
• 公司份额分析
• 产品基准
• 值得关注的重点公司
• 拥有颠覆性技术的公司
• 创业公司

第 11 章公司简介

• GE Healthcare Inc.
  • 公司简介
  • 产品组合和描述
  • 主要亮点
  • 财务摘要
• Bodystat
• Cosmed S.R.L
• Hologic Inc.
• Inbody Co. Ltd
• Jawon Medical Co. Ltd
• Maltron International Ltd
• Zhengzhou YKinspection Enterprise Co., Ltd.
• Chongqing Xishan Science & Technology Co., Ltd
• Guangzhou Lety Medical Limited（*LIST NOT EXHAUSTIVE）

第 12 章DataM

Market Overview

Body Composition Analyzers Market is estimated to reach at a CAGR of 11.2% during the forecast period (2022-2029).

The body composition analyzer works based on bioelectrical impedance analysis (BIA). A method of measuring impedance by applying alternate electrical currents to a user, measuring their volume of water through impedance values, is known as bioelectrical impedance analysis. Body composition analysis can accurately show changes in muscle mass, body fat percentage, and fat mass.

Market Dynamics

The increasing population of obese patients and increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market.

In an attempt to solve some of the key social and environmental determinants of overweight and its underlying unhealthy lifestyles, countries worldwide have significantly up-scaled their policy actions. The government plays an important role in addressing lifestyle behaviors and population health, reducing health disparities and chronic disease. Government involvement includes surveillance, programming, research, quality assurance, access to health care, and guidelines for diet and physical activity(PA). Some view government as paternalistic and favor individual choice. However, there is an opportunity to unite diverse approaches with the government working across sectors and engaging the private sector. Hence, the government's initiatives to promote a healthy lifestyle will increase the awareness of the use of body composition analyzers to assess the proportion of fat to fat-free mass in the body.

The increasing population of obese patients will drive the body composition analyzers market.

According to A-Mansia Biotech, Worldwide prevalence of obesity the worldwide prevalence of obesity nearly tripled between 1975 and 2020. In fact, in 2020, more than 2 billion adults (39% of the global adult population) were overweight (BMI > 25). Of these, over 600 million were obese (BMI > 30). In Europe, more than half the population is overweight (BMI > 25), and up to 30% are obese (BMI > 30). Moreover, the World Obesity Atlas 2022, published by the World Obesity Federation, expects that one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030. The most frequently used measure of obesity is body weight. In general, people with high body weights have higher amounts of body fat. Weight changes correspond to body water, fat, and lean tissue changes. Body composition is a method in which the body is divided into its core components: fat, minerals, protein, and body water. It describes weight more accurately and provides a better look into overall health than traditional methods. Body composition analysis can show real changes in fat mass, muscle mass, and body fat percentage. There are many benefits of doing a BCA now that it has surpassed the outdated Body Mass Index (BMI). There is more to being healthy than losing weight. There are important factors like increasing physical activity and improving the muscle-to-fat ratio. Thus, from the above statements, the market is expected to drive in the forecast period.

Disadvantages related to body composition analyzers will hamper its market.

Although modern technologies and assessment have helped evolve body fat analysis, there are still certain shortcomings, especially depending on the chosen method. The limitation of the method of body fat analysis is that it considers only a few areas that give room for substantial errors. This shortcoming can be avoided if the same area is used repeatedly to check the increase or decrease in body fat over time. Bioelectrical impedance is not very accurate as it works fast, which compels a compromise on accuracy, which makes the concept not so perfect. Other than fat, hydration levels in the body would also influence the response time, food, and other factors.

Depending on where one lives, DEXA scans can be quite expensive and how many centers or Fitness Clubs & Wellness Centers are around to carry the equipment needed. This is an advanced technology, and one may not have many options in a neighborhood or town.

Industry Analysis

The body composition analyzers market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

COVID-19 pandemic is expected to have a fairly positive impact on the market. As suggested by some studies, the risk of contraction of COVID-19 is more in obese patients. Additionally, with lockdown and staying at home, people have become more sedentary than before. Hence, this will drive the body composition analyzers market.

Segment Analysis

The Bio-impedance analyzer segment is expected to hold the largest market share in the body composition analyzers market.

The bio-impedance analyzer segment accounted for the largest share in 2021. It is a method of assessing body composition known as Bioimpedance Analysis (BIA). It is the measurement of body fat in relation to lean body mass. One integral part of a health and nutrition assessment is BIA. It also provides a measurement of fluid and body mass that can be a critical assessment tool for the current state of health. This non-invasive test involves the placement of two electrodes on the right hand and foot of a person. An imperceptible low-level electrical current is sent through the body, and the amount of water in the body will affect the current flow. The device measures how this signal is delayed through different types of tissue. Tissues that contain large amounts of fluid and electrolytes, such as blood, have high conductivity, but fat and bone slow the signal down. The resistance to the flow of the current passing through the body is determined by BIA, which estimates body water from which body fat is calculated using selected equations. For instance, bodivis BCA-2A records key body composition indexes accurately and shows changes like muscle mass, protein, body water and body fat percentage. This can help by validating patient care, corporate wellness and personal training. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

The hospital's segment is expected to hold the largest market share in the body composition analyzers market.

Hospitals with their large scale, strong financial capabilities, and broad range of services will see an increase in this segment. To provide a long-term solution for the treatment of obese individuals, the procedures must be simple and safe to perform, with the device's efficacy maintained throughout long treatment durations. This non-invasive technique involves the placement of electrodes on the feet, hands, or both of a person. An electrical current of low-level is sent through the body, and the current flow is affected by the amount of body water. BIA device measures this signal impeded through different tissue types (muscle has high conductivity, but fat slows the signal down). To reduce the risk of these devices, it's better to use them in a hospital setting. Hospitals provide the best medical practitioner and advanced medical devices. Hence, this segment will dominate the market.

Geographical Analysis

North American region is expected to hold the largest market share in the global body composition analyzers market.

The North American region accounted for the largest market share in 2021. The region's growth is attributed to the increasing prevalence of obesity, and rising product launches by the market players are some factors expected to boost the region in the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), the proportion of US children, who are overweight or obese, which has climbed steadily for years, surged to unprecedented levels during the pandemic. Among a cohort of 432 302 people aged 2-19 years, the body mass index (BMI) increase roughly doubled during the pandemic compared with the preceding period. The greatest increases were seen in children aged 6-11 and those already overweight before the pandemic.

Moreover, the Centers for Disease Control and Prevention reported that the number of states in which at least 35% of residents self-report obesity increased in 2020 from 12 to 16 and therefore, the US is the world's most overweight large country, with an average BMI of 26.6 in men and 26.5 in women. Therefore, it has increased the demand for body composition analyzers. Additionally, at CES Las Vegas in January 2020, Inbody USA will formally debut the InBody 970. The InBody 970, when used in conjunction with the Yscope, analyses and categorizes abdominal fat and total body water using new patented technology. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the body composition analyzers market are Bodystat, Cosmed S.R.L, GE Healthcare Inc., Hologic Inc., Inbody Co. Ltd, Jawon Medical Co. Ltd, Maltron International Ltd, Omron Healthcare Inc., Seca GmbH & Co. Kg., and Tanita Corporation, Zhengzhou YKinspection Enterprise Co., Ltd., Chongqing Xishan Science & Technology Co., Ltd, Guangzhou Lety Medical Limited.

InBody Co Ltd:

Overview:

InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.

Product Portfolio:

InBody 270: The portable and precise InBody 270 body composition analyzer provides accurate analysis for professionals on the go. Delivers standard measurements like Percent Body Fat, Skeletal Muscle Mass, BMR, and more.

The global body composition analyzers market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

• 3.1. Market Snippet By Product
• 3.2. Market Snippet By End User
• 3.3. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The increasing population of obese patients will drive the body composition analyzers market
    • 4.1.1.2. Increasing efforts by the government to promote a healthy lifestyle will drive the body composition analyzers market
  • 4.1.2. Restraints:
    • 4.1.2.1. Disadvantages related to body composition analyzers will hamper its market
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Epidemiology Analysis
• 5.3. Supply Chain Analysis
• 5.4. Pricing Analysis
• 5.5. Regulatory Analysis
• 5.6. Reimbursement Analysis
• 5.7. Unmet Needs

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.1.2. Market Attractiveness Index, By Product Segment
• 7.2. Bio-impedance Analyzer *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
• 7.3. Dual Energy X-ray Absorptiometry Equipment
• 7.4. Skinfold Calipers
• 7.5. Air Displacement Plethysmography Equipment
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 8.1.2. Market Attractiveness Index, By End User Segment
• 8.2. Hospitals *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
• 8.3. Fitness Clubs & Wellness Centers
• 8.4. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Key Developments and Strategies
• 10.2. Company Share Analysis
• 10.3. Product Benchmarking
• 10.4. Key Companies to Watch
• 10.5. Company with disruptive technology
• 10.6. Start Up Companies

11. Company Profiles

• 11.1. GE Healthcare Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Bodystat
• 11.3. Cosmed S.R.L
• 11.4. Hologic Inc.
• 11.5. Inbody Co. Ltd
• 11.6. Jawon Medical Co. Ltd
• 11.7. Maltron International Ltd
• 11.8. Zhengzhou YKinspection Enterprise Co., Ltd.
• 11.9. Chongqing Xishan Science & Technology Co., Ltd
• 11.10. Guangzhou Lety Medical Limited(*LIST NOT EXHAUSTIVE)

12. DataM Intelligence

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us